Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HYAL AT2101

Drug Profile

HYAL AT2101

Alternative Names: Diclofenac + HA topical; Hyaluronic acid + diclofenac; Hyanalgese-D; Oralease

Latest Information Update: 11 Dec 2007

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SkyePharma Inc
  • Developer Pacira Pharmaceuticals; SkyePharma Inc; Symbion Health
  • Class Glycosaminoglycans; Nonsteroidal anti-inflammatories; Phenylacetates
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Aphthous ulcer pain; Pain; Rheumatic disorders

Most Recent Events

  • 08 Dec 1998 Phase-III clinical trials for Aphthous ulcer pain in USA (Topical)
  • 01 Oct 1998 Hyal Pharmaceutical has acquired the rights to HYAL AT2101 in Asian countries, which had been licensed to its Australian subsidiary
  • 12 Feb 1998 Discontinued-III for Pain in Austria (Topical)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top